Thoratec to report on its growth at national meeting today

Pleasanton company is recognized leader in therapies to address advanced-stage heart failure

Thoratec Corporation, a Pleasanton-based developer of mechanical circulatory support therapies to save, support and restore failing hearts, will be participating in the Canaccord Genuity 34th Annual Growth Conference today.

The conference, to be held at the Intercontinental Hotel in Boston, is sponsored by Canaccord Genuity, a Canadian banking and financial services company that specialises in wealth management and brokerage in capital markets.

Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on Thoratec starting at 11 a.m. Pacific time.

A webcast of the presentation will be available at, or on the company's website at

Thoratec is a leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate II® and HeartMate III(TM) LVAS (Left Ventricular Assist Systems) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure.

Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS®, and HeartMate PHP(TM) product lines.

Thoratec's headquarters are on Johnson Drive in Pleasanton.

For more information, visit the company's website at


Sorry, but further commenting on this topic has been closed.

GE's re-organization reaches San Ramon digital headquarters
By Tim Hunt | 3 comments | 1,969 views

Sound and Fury over Vile and Slur-ry
By Tom Cushing | 77 comments | 1,181 views

New state housing requirements could affect Pleasanton
By Jeb Bing | 4 comments | 468 views